Levels of about 100 proteins were found to differ in the AD brain and Cerebral Spinal Fluid (CSF) with respect to the control brain and CSF, with the biggest changes seen in the glial fibrillary acidic protein (GFAP) (Liao et al. 2004). This evidence concerns the gene GFAP and Alzheimer disease.